In DCM, hyperglycemia also facilitates AGE binding to Myeloid Differentiation Protein 2 (MD2) transporters, forming an AGE–MD2–TLR4 complex that activates pro-inflammatory pathways. The gene discussed is LY96; the disease is Hyperglycemia.